FDA Enforcement Class II Ongoing

K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

Recall: Z-0271-2023 · Reported November 30, 2022

Enforcement

Recall Number
Z-0271-2023
Event ID
91030
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Kamiya Biomedical Company, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
November 30, 2022
Initiation Date
September 28, 2022
Classification Date
November 21, 2022
Address
12779 Gateway Dr S, N/A, Tukwila, WA, 98168-3308, United States

Description

K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

Reason

IgA Reagent may start showing cloudiness over time, which can affect assay performance.

Code Info

UDI-DI: 00816426020092, Lot/ Expiration Date: H180/ 2023-01-31, K181/ 2023-03-31, N182/ 2023-06-30, D283/ 2023-09-30

Distribution

Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.

Quantity

165